And, of course, if no partnership deal with MNK is concluded, then they can always tap equity markets again, as they have done every year.
And then there's also Celgene in the background, with its powerhouse balance sheet. I wonder when things will be finalised with Celgene, either way, because it has been more than 2 years that Celgene and MSB have been in talks.
MSB Price at posting:
$3.18 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)